Related Experiment Video
Updated: Feb 8, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Integrin α9 Suppresses Hepatocellular Carcinoma Metastasis by Rho GTPase Signaling
Yan-Li Zhang1, Xin Xing2, Li-Bo Cai3
1State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200240, China.
Abstract:
Integrin subunit alpha 9 (ITGA9) mediates cell-cell and cell-matrix adhesion, cell migration, and invasion through binding different kinds of extracellular matrix (ECM) components. However, its potential role and underlying molecular mechanisms remain unclear in hepatocellular carcinoma (HCC). Here, we found that ITGA9 expression was obviously decreased in patients with HCC, which was negatively correlated with HCC growth and metastasis. ITGA9 overexpression significantly inhibited cell proliferation and migration in vitro as well as tumor growth and metastasis in vivo. Our data demonstrated that the inhibitory effect of ITGA9 on HCC cell motility was associated with reduced phosphorylation of focal adhesion kinase (FAK) and c-Src tyrosine kinase (Src), disrupted focal adhesion reorganization, and decreased Rac1 and RhoA activity. Our data suggest ITGA9, as a suppressor of HCC, prevents tumor cell migration and invasiveness through FAK/Src-Rac1/RhoA signaling.
Insights
Integrin subunit alpha 9 (ITGA9) acts as a tumor suppressor in liver cancer. Its reduced expression correlates with increased hepatocellular carcinoma (HCC) growth and metastasis, highlighting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Integrin subunit alpha 9 (ITGA9) plays a role in cell adhesion and migration.
- The specific function and molecular mechanisms of ITGA9 in hepatocellular carcinoma (HCC) are not well understood.
Purpose of the Study:
- To investigate the role of ITGA9 in hepatocellular carcinoma (HCC).
- To elucidate the underlying molecular mechanisms of ITGA9's function in HCC progression.
Main Methods:
- Analysis of ITGA9 expression in HCC patient samples.
- In vitro and in vivo experiments involving ITGA9 overexpression.
- Assessment of signaling pathways including FAK, Src, Rac1, and RhoA.
Main Results:
- ITGA9 expression is significantly decreased in HCC and negatively correlates with tumor growth and metastasis.
- Overexpression of ITGA9 inhibits HCC cell proliferation, migration, and tumor growth in vivo.
- ITGA9 suppresses HCC cell motility by reducing FAK/Src phosphorylation and Rac1/RhoA activity, disrupting focal adhesion.
Conclusions:
- ITGA9 functions as a suppressor of HCC.
- ITGA9 inhibits tumor cell migration and invasiveness via the FAK/Src-Rac1/RhoA signaling pathway.
- ITGA9 represents a potential therapeutic target for HCC treatment.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Cell Polarization by Rho Proteins

